17/12/2018
Our spin-off company GlyCardial Diagnostics has received the SME instrument phase II funding of the H2020 programme
We are proud to anounce that our spin-off company GlyCardial Diagnostics has received the SME instrument phase II funding of the H2020 programme to advance in the development of our novel test f...